TOLLIP inhibits lipid accumulation and the integrated stress response in alveolar macrophages to control Mycobacterium tuberculosis infection
Nature Microbiology · 2024
DOI: 10.1038/s41564-024-01641-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Nature Microbiology, 2024. Verfasst von Sambasivan Venkatasubramanian und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Washington, Seattle, WA, USA. Hauptthemen laut MEDLINE: Tuberculosis, Mycobacterium tuberculosis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
A polymorphism causing deficiencies in Toll-interacting protein (TOLLIP), an inhibitory adaptor protein affecting endosomal trafficking, is associated with increased tuberculosis (TB) risk. It is, however, unclear how TOLLIP affects TB pathogenesis. Here we show that TB severity is increased in Tollip-/- mice, characterized by macrophage- and T cell-driven inflammation, foam cell formation and lipid accumulation. Tollip-/- alveolar macrophages (AM) specifically accumulated lipid and underwent necrosis. Transcriptional and protein analyses of Mycobacterium tuberculosis (Mtb)-infected, Tollip-/- AM revealed increased EIF2 signalling and downstream upregulation of the integrated stress response (ISR). These phenotypes were linked, as incubation of the Mtb lipid mycolic acid with Mtb-infected Tollip-/- AM activated the ISR and increased Mtb replication. Correspondingly, the ISR inhibitor, ISRIB, reduced Mtb numbers in AM and improved Mtb control, overcoming the inflammatory phenotype. In conclusion, targeting the ISR offers a promising target for host-directed anti-TB therapy towards improved Mtb control and reduced immunopathology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of Washington, Seattle, WA, USA.
- Seattle Children's Research Institute, Seattle, WA, USA.
- Department of Pediatrics, University of Washington, Seattle, WA, USA.
- Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
- VA Ann Arbor Healthcare System, Ann Arbor, MI, USA.
- Departments of Pediatrics and Immunology, University of Washington, Seattle, WA, USA.
Förderung
- NIAID NIH HHS
- NHLBI NIH HHS
- NIDDK NIH HHS
- BLRD VA
- U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
- American Diabetes Association
- U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
- U.S. Department of Veterans Affairs
Zitieren
APA
Venkatasubramanian, S., Plumlee, C. R., Dill-McFarland, K. A., Cohen, S. B., Gern, B. H., Rane, D. A., Meyer, M. K., Saha, A., Hinderstein, S. A., Pearson, G. L., Lietzke, A. C., Pacheco, A., Chow, Y. H., Hung, C. F., Soleimanpour, S. A., Altman, M., Urdahl, K. B., & Shah, J. A. (2024). TOLLIP inhibits lipid accumulation and the integrated stress response in alveolar macrophages to control Mycobacterium tuberculosis infection. Nature Microbiology. https://doi.org/10.1038/s41564-024-01641-w
Vancouver
Venkatasubramanian S, Plumlee CR, Dill-McFarland KA, Cohen SB, Gern BH, Rane DA, et al. TOLLIP inhibits lipid accumulation and the integrated stress response in alveolar macrophages to control Mycobacterium tuberculosis infection. Nature Microbiology. 2024. doi:10.1038/s41564-024-01641-w
BibTeX
@article{Venkatasubramanian2024,
author = {Venkatasubramanian, Sambasivan and Plumlee, Courtney R and Dill-McFarland, Kimberly A and Cohen, Sara B and Gern, Benjamin H and Rane, Divya A and Meyer, Mackenzie K and Saha, Aparajita and Hinderstein, Sarah A and Pearson, Gemma L and Lietzke, Anne C and Pacheco, Amanda and Chow, Yu-Hua and Hung, Chi F and Soleimanpour, Scott A and Altman, Matthew and Urdahl, Kevin B and Shah, Javeed A},
title = {TOLLIP inhibits lipid accumulation and the integrated stress response in alveolar macrophages to control Mycobacterium tuberculosis infection},
journal = {Nature Microbiology},
year = {2024},
doi = {10.1038/s41564-024-01641-w}
}
EUVIMED